EU also approves AstraZeneca vaccine use…獨·佛·Italy “Effect question”

-The European Union (EU) approved AstraZeneca’s novel coronavirus infection (Corona 19) vaccine on the 29th of last month (local time) under the condition that it should be used over the age of 18, but controversy continues over the effectiveness of this vaccine to the elderly. . Among EU member states, France, Germany, and Italy, which have strong voices, are still questioning the effectiveness of AstraZeneca vaccine inoculation for the elderly. These three countries rank first or third in population among 27 EU member states. When the population of the three countries is added, it is approximately 215 million, which is 47% of the total EU population of 4477.7 million.

French President Emmanuel Macron expressed strong doubts about the effectiveness of the AstraZeneca vaccine inoculating elderly people, saying, “I think it is not effective for people over 65 years old.” President Macron’s remarks came a few hours before the European Medicines Agency (EMA) recommended approval for use by the EU Commission. The previous day, the immunization committee under the Robert Koch Institute, a German disease control agency, also recommended that “AstraZeneca vaccine should be vaccinated only in the ages of 18-64” through the draft vaccination guidelines. It is said that the effect on the elderly over the age of 65 has not been confirmed.

In Italy, even though EU approval was issued, it was recommended to refrain from vaccinating the elderly with AstraZeneca vaccine. On the 30th, the Italian Medicines Agency (AIFA) approved the use of the vaccine for adults over 18 years of age, but recommended that adults under the age of 54 be given the vaccine first. In the meantime, it was recommended that Pfizer, modder, or vaccines be given priority to those over 55. As such, it is pointed out that one of the reasons why major EU countries continue to question the effectiveness of AstraZeneca vaccine inoculation for the elderly, due to the unclear explanation of the European Medicines Agency (EMA). EMA said on the 29th of last month, when the AstraZeneca vaccine was approved, “there is not enough data yet to show how effective the vaccine is for people over 55 years of age.” I thought it was okay.”
Paris = Correspondent Yunjong Kim [email protected]Go to reporter page>